NCT03848663Recruiting
Visual Remapping to Aid Reading With Field Loss
Remapping the Visual Field to Aid Reading With Central Scotomas
Source: ClinicalTrials.gov · Last updated 8 Jul 2026
Brief summary (registry, in English)
Reading performance in patients with Central Vision Loss and age matched controls with artificial scotomas will be measured with and without different kinds of remapping of missing text to different parts of the visual field.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 108 (estimated)
- First submitted
- 28 Jan 2019
- Start date
- 1 Feb 2022
- Primary completion date
- 1 Nov 2026
- Lead sponsor
- University of Minnesota
- Diseases
- Macular degeneration
- NCT number
- NCT03848663
What you commit to
- Study type: Interventional
- Planned participants: 108
- From 1 Feb 2022 to the primary completion date, 1 Nov 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Cognitive impairment as indicated by a Mini-Mental State Examination (MMSE).
Other
- Central vision loss of less than 5 deg diameter; scotomas that do not cover the fovea; unilateral scotomas
- Poor fixation (worse than+/- 1 deg) using their PRL.
- Satisfactory calibration not achievable using eye tracker
Who the study is looking for
- 16 years or older
- Central vision loss of at least 5 deg diameter, including the fovea, from bilateral central scotomas
- Stable fixation (+/- 1 deg) using their PRL.
- No cognitive impairment as indicated by a Mini-Mental State Examination (MMSE).
- Satisfactory calibration achievable using eye tracker
Age in the registry: 16 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Minnesota Coordinator of this site? Confirm its status | Minneapolis | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.